ストックスクリーナーアプリを入手
10.45
0.10%
-0.06
前日終値:
$10.39
開ける：
$10.41
24時間の取引高:
8,924
Relative Volume:
0.08
時価総額：
$173.01M
収益：
-
当期純損益:
$-14.72M
株価収益率:
-3.6926
EPS:
-2.83
ネットキャッシュフロー:
$-7.41M
1週間 パフォーマンス:
-5.64%
1か月 パフォーマンス:
+14.13%
6か月 パフォーマンス:
+74.16%
1年 パフォーマンス:
+0.00%
1日の値動き範囲:
$10.36
$10.59
1週間の範囲:
$10.03
$11.20
52週間の値動き範囲:
$3.75
$11.54
Alpha Cognition Inc Stock (ACOG) Company Profile
ACOG を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
ACOG
Alpha Cognition Inc
|
10.40 | 173.01M | 0 | -14.72M | -7.41M | -2.83 |
|
VRTX
Vertex Pharmaceuticals Inc
|
466.47 | 123.00B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
549.69 | 59.66B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
321.86 | 41.84B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
568.10 | 33.98B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
288.99 | 27.67B | 3.81B | -644.79M | -669.77M | -6.24 |
Alpha Cognition Inc Stock (ACOG) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-03-18 | 開始されました | H.C. Wainwright | Buy |
Alpha Cognition Inc (ACOG) 最新ニュース
What makes Alpha Cognition Inc. stock price move sharplyCapital Safe Stock Watchlist - Newser
How Alpha Cognition Inc. stock performs during market volatilityMinimized Risk Maximum Return - Newser
Why Alpha Cognition Inc. stock attracts strong analyst attentionProtected Capital Trading Plan - Newser
Alpha Cognition Inc.'s (NASDAQ:ACOG) market cap surged US$24m last week, retail investors who have a lot riding on the company were rewarded - simplywall.st
Alpha Cognition to Present ZUNVEYL® (Benzgalantamine) Study Data at Alzheimer’s Association International Conference - BioSpace
What Makes Alpha Cognition Inc. (ACOG) a New Strong Buy Stock - MSN
H.C. Wainwright reiterates Buy rating on Alpha Cognition stock, citing promising mTBI data By Investing.com - Investing.com South Africa
H.C. Wainwright reiterates Buy rating on Alpha Cognition stock, citing promising mTBI data - Investing.com India
Promising Preclinical Data on ALPHA-1062 Supports Buy Rating for Alpha Cognition - TipRanks
Alpha Cognition reports positive preclinical data for brain injury drug - Investing.com India
Alpha Cognition reports positive preclinical data for brain injury drug By Investing.com - Investing.com Nigeria
Alpha Cognition shares preclinical data for TBI drug ALPHA-1062 - TipRanks
Alpha Cognition Announces Positive Pre-Clinical Data for ALPHA-1062 Use in a Military Relevant Model of Repetitive Mild Traumatic Brain Injury - Business Wire
Should You Buy Alpha Cognition Inc. (ACOG) After Golden Cross? - Yahoo Finance
Tenaya Therapeutics (NASDAQ:TNYA) and Alpha Cognition (NASDAQ:ACOG) Critical Survey - Defense World
Alpha Cognition Inc. Common Stock (NASDAQ:ACOG) Q1 2025 Earnings Call Transcript - MSN
Alpha Cognition Inc. Common Stock (ACOG): A Bull Case Theory - Insider Monkey
Rare Stock Picks In May 2025From 27 Discerning Analysts - Seeking Alpha
Alpha Cognition: Launching A Differentiated Drug Into A Large Alzheimer's Market Opportunity - Seeking Alpha
Stonegate Capital Partners Updates Coverage on Alpha Cognition Inc. (ACOG) Q1 2025 - TradingView
Alpha Cognition (NASDAQ:ACOG) Earns “Buy” Rating from HC Wainwright - Defense World
We Think Alpha Cognition (NASDAQ:ACOG) Can Easily Afford To Drive Business Growth - Yahoo Finance
Alpha Cognition Inc. Reports Strong Q1 2025 Performance - TipRanks
Alpha Cognition’s Earnings Call Highlights Success and Growth - TipRanks
Alpha Cognition’s Strong Financial Performance and Promising Alzheimer’s Treatment Drive Buy Rating - TipRanks
Alpha Cognition Inc. (ACOG) Reports Q1 Loss, Misses Revenue Estimates - Yahoo Finance
Alpha Cognition Q1 2025 Earnings Call Transcript - MarketBeat
ALPHA COGNITION Earnings Results: $ACOG Reports Quarterly Earnings - Nasdaq
Alpha Cognition Inc. SEC 10-Q Report - TradingView
Alpha Cognition Inc. Reports First Quarter 2025 Financial Results and Operating Overview - BioSpace
Alpha Cognition (ACOG) Expected to Announce Earnings on Tuesday - Defense World
Alpha Cognition, Inc.’s (NASDAQ:ACOG) Lock-Up Period To Expire on May 12th - Defense World
Will Alpha Cognition's Recently Launched Alzheimer's Drug Be A Commercial Success? - RTTNews
Alpha Cognition to Report First Quarter 2025 Financial Results and Operating Overview - BioSpace
Alpha Cognition, Inc. Announces Participation in the D. Boral Capital Inaugural Global Conference - The Kingston Whig Standard
Alpha Cognition to Present ZUNVEYL® (Benzgalantamine) Clinical Data at 2025 Alzheimer’s Association International Conference - Yahoo Finance
Alpha Cognition Inc. Reports Strong 2024 Financials - TipRanks
Alpha Cognition Strengthens Its Leadership Team with Appointment of Robert Wills to Board of Directors and Announces Departure of Existing Director John Havens - BioSpace
Alpha Cognition announces board changes - Investing.com
Alpha Cognition announces board changes By Investing.com - Investing.com Canada
Alpha Cognition Inc (ACOG) 財務データ
収益
当期純利益
現金流量
EPS
Alpha Cognition Inc (ACOG) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| MERTZ LEONARD POWELL | Director |
Nov 13 '24 |
Buy |
5.75 |
8,695 |
49,996 |
93,725 |
| HAVENS JOHN PRENTISS | Director |
Nov 13 '24 |
Buy |
5.75 |
4,347 |
24,995 |
273,272 |
3.69%
2.49%
大文字化:
|
ボリューム (24 時間):